Veracyte (VCYT) Acquisitions (2014 - 2024)

Veracyte (VCYT) posted quarterly Acquisitions of -$5.0 million for Q1 2024, down 100.87% on a QoQ basis from $574.4 million in Q1 2021.

Veracyte (VCYT) Acquisitions (2014 - 2024) Analysis & Trends

Veracyte has reported Acquisitions for 3 years, with the latest figure at -$5.0 million in Q1 2024.

  • Acquisitions for Q1 2024 came in at -$5.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$5.0 million (changed N/A YoY), and the FY2024 annual result was -$5.0 million, changed N/A from the prior year.
  • Acquisitions fell to -$5.0 million in Q1 2024, from $574.4 million in the prior quarter.
  • Over five years, Acquisitions peaked at $574.4 million in Q1 2021 and troughed at -$5.0 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn -
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn -
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn -
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn 163.00 Mn
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn -
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn 2.00 Mn
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn -
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn -
10 Veracyte 3.69 Bn 3.39 Bn 108.55 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 -5.01 Mn
Mar 31, 2021 574.41 Mn
Dec 31, 2014 30,000.00